The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth advocates argue that two of these rules hinder access to care. The post Why Telehealth Advocates Are Calling on the Trump Administration to Withdraw New Telemedicine Rules appeared first on MedCity News.
By DAVID INTROCASO In late July the UN International Court of Justice (ICJ) announced its long-awaited and highly-anticipated climate advisory opinion. The ICJ ruling represents an historic moment in climate accountability. “Obligations of States in Respect of Climate Change” In a rare unanimous decision, the ICJ opinion concluded “a clean, healthy and sustainable environment” is in…
It’s a bold attempt to recalibrate global drug pricing — with U.S. patients at the center. But without clear enforcement, legal grounding, or international cooperation, its future remains very uncertain. The post The MFN Executive Order: A Global Reset for U.S. Pharma appeared first on MedCity News.
Creating adequate capacity for any therapeutic can be challenging, and the specialized technologies for manufacturing complex biologics require flexibility and agility in production processes. Here’s how contract development and manufacturing organizations (CDMOs) ensure that biopharmaceutical companies have a partner with the speed, flexibility, and expertise necessary for successful drug development and manufacturing. The post Evolving…
In 2025, more than half (54%) of eligible Medicare beneficiaries are enrolled in Medicare Advantage plans. This brief provides current information about Medicare Advantage enrollment, by plan type and firm, and shows how enrollment varies by state and county.
APG CEO Susan Dentzer believes that now is indeed the time to act to improve Medicare and Medicare Advantage
About one in five in-network claims were denied by insurers of qualified health plans on HealthCare.gov in 2023, according to KFF. There is also wide variation by insurer and state. The post Report: HealthCare.gov Insurers Denied 19% of In-Network Claims in 2023 appeared first on MedCity News.
On May 2, 2025, the White House released preliminary details of its FY26 budget request, including funding for global health activities at the State Department, U.S. Agency for International Development (USAID), Centers for Disease Control and Prevention (CDC), and the Fogarty International Center (FIC) at National Institutes of Health (NIH). While funding amounts for most…More
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
AI can be a highly effective tool for plans aiming to reduce fraud, waste and abuse, but only if it is combined with investigative intelligence. The post AI: A Good Tool to Combat Bad Actors in Healthcare appeared first on MedCity News.